opponents of the plan see little in the way of potential benefits from the plan, except increased profits for pharmaceutical companies, and have concerns about the potential for unnecessarily causing neurological damage and contributing to increased substance abuse and drug dependence. critics are also concerned by what they see as the pharmaceutical industry's use of front organizations and the compromise of scientific integrity under color of authority, look askance at the irony of the commission's 'freedom' descriptor, contending the commission is yet another example of the excesses of drug industry marketing, and that the effects of its recommendations will simply foster drug use rather than the prevention of mental illness and use of alternative treatment modalities.